While GLP-1 medications help regulate appetite and blood sugar, NAD+ supports cellular function and vitality, potentially aiding in sustaining progress
The fact that covering GLP-1s under Medicare Part D for authorized uses is already making a mark on total Part D program spending could be a sign of even higher spending to come as Part D plans are now able to cover Wegovy for its heart health benefits, as other uses for GLP-1s are approved, and as policymakers consider legislation that would authorize Medicare to cover obesity drugs
The Obesity Medicine Association strongly recommends that individuals stop taking these medications before attempting to conceive
Labs are not required to start treatment, but Lavender Sky lets patients upload existing lab work to the portal or order an at-home lab kit (roughly $175$250 at the patients expense) if they want a baseline
Large clinical trials study these medications at the doses approved or under evaluation by the FDA
Cost savings alone do not qualify, and prescribing decisions should be supported by appropriate clinical judgment and documentation